| ETRASIMOD ARGININE | None | ||
| 2MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| VELSIPITY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis in adults. | |||
|
Yes
| |||
| VELSIPITY | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 |
|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||
| *********** *,*,*,*-********************[*]*****-*-**)****** **** *********** ****** ** *** ********* ** ********** *** ************ ********* | *********** *,*,*,*-********************[*]*****-*-**)****** **** *********** ****** ** *** ********* ** ********** *** ************ ********* | *********** *-******** **** ** (*)-*-(*-(*-***********-*-(***************)*********)-*,*,*,*-***************-***** [*]*****-*-**)****** ****(********) *** *** ** **** ********-********** ********* | *********** *-******** **** ** (*)-*-(*-(*-***********-*-(***************)*********)-*,*,*,*-***************-***** [*]*****-*-**)****** ****(******** *) *** *** ** **** ********-********** ********* | ******* ** ******** ********** ******* ** *** **** ******** | *********** *-******** **** ** (*)-*-(*-(*-***********-*-(***************)*********)-*,*,*, *-***************-***** [*]*****-*-**)****** ****(*********) *** *** ** **** ********-********** ********* | *********** *-******** **** ** (*)-*-(*-(*-***********-*-(***************)*********)-*,*,*,*-***************-***** [*]*****-*-**)****** ****(*********) *** *** ** **** ********-********** ********* | ******* ** ******** ********** ******* ** *** **** ******** | ******* ** ******** ********** ******* ** *** **** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|